Trial intelligence / Profile preview

10-Day High-Dose vs 14-Day Standard-Dose Vonoprazan + Amoxicillin for H. pylori

NCT07720037Phase 4Not yet recruiting

Sponsor
Shandong University
Start
Sep 2026
Primary completion
Sep 2026
01

Overview

A Phase 4 trial of vonoprazan in Helicobacter pylori infection, sponsored by Shandong University. Planned start Sep 2026; status: not yet recruiting.

02

Drugs

vonoprazan
03

Conditions

Helicobacter pylori infection

Beyond the preview

Go deeper on NCT07720037.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07720037.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call